Analyst consensus rating
Entera Bio Analyst Rating: none
ENTX is rated none by 1 analysts with a $9.00 target. As of 2026-08-24.
Direct answer
Entera Bio's consensus rating is none.
1 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $9.00.
Forecast evidence checked August 24, 2026.
Get free Entera Bio email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $3.23
- Average price target
- $9.00
- High price target
- $9.00
- Low price target
- $9.00
- Low target gap
- +178.6%
- Target upside
- +178.6%
- High target gap
- +178.6%
- Target range width
- 0%
- Consensus rating
- none
- Analysts
- 1
- Evidence date
- August 24, 2026
- Valid through
- August 31, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for Entera Bio?
Entera Bio has a verified none consensus. The same dataset has an average price target of $9.00.
How far are Entera Bio's low and high targets from the recorded price?
The low target implies +178.6%, while the high target implies +178.6%.
How many analysts are included in Entera Bio's consensus?
The verified consensus includes 1 analysts.
How is Entera Bio's target upside or downside calculated?
The average target of $9.00 is divided by the recorded price of $3.23, then one is subtracted to produce +178.6%. This does not guarantee a future return.
When was Entera Bio's analyst forecast verified?
The data was verified on 2026-08-24. The dataset is valid through 2026-08-31.